These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1825515

  • 21. Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.
    Adami S, Salvagno G, Guarrera G, Bianchi G, Dorizzi R, Rosini S, Mobilio G, Lo Cascio V.
    J Urol; 1985 Dec; 134(6):1152-4. PubMed ID: 2932559
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A, Chantraine A, Donath A, van Ouwenaller C, Turnill D, Mermillod B, Kitler ME.
    N Engl J Med; 1983 Jun 23; 308(25):1499-501. PubMed ID: 6222257
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
    Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S.
    J Clin Oncol; 1993 Jan 23; 11(1):59-65. PubMed ID: 8418243
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy.
    Piga A, Bracci R, Ferretti B, Sandri P, Nortilli R, Acito L, Pancotti A, Di Furia L, Carle F, Cellerino R.
    J Exp Clin Cancer Res; 1998 Jun 23; 17(2):213-7. PubMed ID: 9700583
    [Abstract] [Full Text] [Related]

  • 30. Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyroparathyroidectomized rats.
    Weisbrode SE, Capen CC, Pendley CB.
    Calcif Tissue Res; 1978 May 26; 25(2):119-26. PubMed ID: 149584
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC, Jee WS.
    Anat Rec; 1979 Mar 26; 193(3):439-62. PubMed ID: 154858
    [Abstract] [Full Text] [Related]

  • 33. Disodium clodronate in the treatment of pain due to bone metastases.
    Luzzani M, Vidili MG, Rissotto R, Nobile MT, Beghè F, Rosso R, Gottlieb A.
    Int J Clin Pharmacol Res; 1990 Mar 26; 10(4):243-6. PubMed ID: 2150406
    [Abstract] [Full Text] [Related]

  • 34. Clodronate in the management of bone metastases: a clinical study of 91 patients.
    Serkies K, Jereczek-Fossa B, Badzio A, Jassem J.
    Neoplasma; 1999 Mar 26; 46(5):317-22. PubMed ID: 10665850
    [Abstract] [Full Text] [Related]

  • 35. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A, van Ouwenaller C, Chantraine A, Donath A, Rosini S.
    N Engl J Med; 1981 Aug 06; 305(6):343-4. PubMed ID: 6454076
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease.
    Harris ST, Neer RM, Segre GV, Petkau AJ, Tully GL, Daly M, Potts JT.
    J Clin Endocrinol Metab; 1982 Dec 06; 55(6):1100-7. PubMed ID: 6215419
    [Abstract] [Full Text] [Related]

  • 39. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD, Chapuy MC, Meunier PJ.
    Horm Metab Res; 1984 May 06; 16(5):258-61. PubMed ID: 6234216
    [Abstract] [Full Text] [Related]

  • 40. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ, Dranitsaris G, Ooi WS, Yogendran G, Sukovic T, Wong BY, Verma S, Pritchard KI, Trudeau M, Cole DE.
    J Clin Oncol; 2006 Oct 20; 24(30):4895-900. PubMed ID: 17001071
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.